These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34828357)

  • 1. Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.
    Ma EZ; Hoegler KM; Zhou AE
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Deep Learning on the Prognosis of Cutaneous Melanoma Based on Full Scan Pathology Images.
    Li A; Li X; Li W; Yu X; Qi M; Li D
    Biomed Res Int; 2022; 2022():4864485. PubMed ID: 36072469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.
    Korfiati A; Grafanaki K; Kyriakopoulos GC; Skeparnias I; Georgiou S; Sakellaropoulos G; Stathopoulos C
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic Analysis of Gene Expression for Melanoma Treatment.
    Kawakami A; Fisher DE
    J Invest Dermatol; 2016 Dec; 136(12):2342-2344. PubMed ID: 27884291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human.
    Shepelin D; Korzinkin M; Vanyushina A; Aliper A; Borisov N; Vasilov R; Zhukov N; Sokov D; Prassolov V; Gaifullin N; Zhavoronkov A; Bhullar B; Buzdin A
    Oncotarget; 2016 Jan; 7(1):656-70. PubMed ID: 26624979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of Tumor Immunogenicity Based Gene Signature for Skin Cancer Risk Stratification.
    Yavartanoo M; Yi GS
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling tumour cell diversity and prognostic signatures in cutaneous melanoma through machine learning analysis.
    Cheng W; Ni P; Wu H; Miao X; Zhao X; Yan D
    J Cell Mol Med; 2024 Jul; 28(14):e18570. PubMed ID: 39054572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle gene networks are associated with melanoma prognosis.
    Wang L; Hurley DG; Watkins W; Araki H; Tamada Y; Muthukaruppan A; Ranjard L; Derkac E; Imoto S; Miyano S; Crampin EJ; Print CG
    PLoS One; 2012; 7(4):e34247. PubMed ID: 22536322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
    Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P
    Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical bioinformatics in melanoma.
    Cheng PF
    Curr Opin Oncol; 2018 Mar; 30(2):113-117. PubMed ID: 29227308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis.
    Song WM; Agrawal P; Von Itter R; Fontanals-Cirera B; Wang M; Zhou X; Mahal LK; Hernando E; Zhang B
    Nat Commun; 2021 Feb; 12(1):1214. PubMed ID: 33619278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
    Wei CY; Zhu MX; Lu NH; Peng R; Yang X; Zhang PF; Wang L; Gu JY
    Oncogene; 2019 Mar; 38(11):1876-1891. PubMed ID: 30385854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of potential prognostic biomarkers in metastatic skin cutaneous melanoma by bioinformatics analysis.
    Sheng Z; Han W; Huang B; Shen G
    J Cell Mol Med; 2020 Oct; 24(19):11613-11618. PubMed ID: 32869947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
    Han W; Huang B; Zhao XY; Shen GL
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs in melanoma.
    Yu X; Zheng H; Tse G; Chan MT; Wu WK
    Cell Prolif; 2018 Aug; 51(4):e12457. PubMed ID: 29582492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning random forest for predicting oncosomatic variant NGS analysis.
    Pellegrino E; Jacques C; Beaufils N; Nanni I; Carlioz A; Metellus P; Ouafik L
    Sci Rep; 2021 Nov; 11(1):21820. PubMed ID: 34750410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.
    Guo W; Zhu L; Zhu R; Chen Q; Wang Q; Chen JQ
    Elife; 2019 Jun; 8():. PubMed ID: 31169496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.